Page results
-
This page has been written for patients who are having a course of radiotherapy for a brain tumour called a meningioma.
-
This information has been written for patients who have been referred for pelvic radiotherapy for a gynaecological cancer.
-
This information has been written for patients who are having internal vaginal radiotherapy treatment (brachytherapy) for a gynaecological cancer.
-
This information has been written for patients who are having radiotherapy treatment to the brain and spine.
-
Once you have completed treatment for cancer at UCLH you will enter a period of follow-up care. Follow-up is an important way of monitoring your health.
-
Our cancer team monitors all urgent, two-week wait, suspected cancer referrals from GPs. All appointments are carefully and systematically monitored to ensure a speedy and efficient patient journey from diagnosis to treatment or discharge.
-
This page explains how our plasma cell multidisciplinary team (MDT) will support you during treatmen
-
Dr Riaz' clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
-
Become a member of UCLH. We want to better reflect the diversity of the communities we serve and meet the needs of our local community, patients and staff.
-
This page explains who you will meet and what to expect at your appointment with the adolescent gynaecology team at UCLH.
File results
-
FOI/2024/0148 - Cleaning audit system at Trust
-
FOI/2024/0149 - National Hospital for Neurology and Neurosurgery (NHNN) admissions 2018-2023
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer
-
FOI/2024/0162 - Various technology systems/ services used at Trust
-
FOI/2024/0163 - Renal cell carcinoma and melanoma treatments
-
FOI/2024/0166 - Recruitment systems/CRM platform
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0172 - Patients excluded from care at the Trust 2010-2023
-
FOI/2024/0179 - Water usage/ procurement
-
FOI/2024/0183 - Immunology Hidradenitis Suppurativa (HS) treatment